Table 4
Open in new tab

Top five “core gene” terms in each annotation category (B&Y FDR less than 1e-10)

CategoryIDNameQ
CoexpressionM15664ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER6.19E-41
CoexpressionM41693TRAVAGLINI_LUNG_PROLIFERATING_MACROPHAGE_CELL2.92E-38
CoexpressionM3766SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP5.99E-38
CoexpressionM16010KOBAYASHI_EGFR_SIGNALING_24HR_DN2.32E-35
CoexpressionM18506CROONQUIST_IL6_DEPRIVATION_DN5.86E-34
DiseaseC2239176Liver carcinoma2.10E-45
DiseaseC4704874Mammary carcinoma, human1.27E-22
DiseaseC1458155Mammary neoplasms1.27E-22
DiseaseC1257931Mammary neoplasms, human1.27E-22
DiseaseC0678222Breast carcinoma2.38E-22
GO: Biological ProcessGO:0033993Response to lipid8.91E-16
GO: Biological ProcessGO:0014070Response to organic cyclic compound1.16E-13
GO: Biological ProcessGO:0043067Regulation of programmed cell death2.65E-13
GO: Biological ProcessGO:0009725Response to hormone2.65E-13
GO: Biological ProcessGO:1903047Mitotic cell cycle process4.21E-13
TFBSM30019HSD17B8_TARGET_GENES1.30E-15
CategoryIDNameQ
CoexpressionM15664ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER6.19E-41
CoexpressionM41693TRAVAGLINI_LUNG_PROLIFERATING_MACROPHAGE_CELL2.92E-38
CoexpressionM3766SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP5.99E-38
CoexpressionM16010KOBAYASHI_EGFR_SIGNALING_24HR_DN2.32E-35
CoexpressionM18506CROONQUIST_IL6_DEPRIVATION_DN5.86E-34
DiseaseC2239176Liver carcinoma2.10E-45
DiseaseC4704874Mammary carcinoma, human1.27E-22
DiseaseC1458155Mammary neoplasms1.27E-22
DiseaseC1257931Mammary neoplasms, human1.27E-22
DiseaseC0678222Breast carcinoma2.38E-22
GO: Biological ProcessGO:0033993Response to lipid8.91E-16
GO: Biological ProcessGO:0014070Response to organic cyclic compound1.16E-13
GO: Biological ProcessGO:0043067Regulation of programmed cell death2.65E-13
GO: Biological ProcessGO:0009725Response to hormone2.65E-13
GO: Biological ProcessGO:1903047Mitotic cell cycle process4.21E-13
TFBSM30019HSD17B8_TARGET_GENES1.30E-15
Table 4
Open in new tab

Top five “core gene” terms in each annotation category (B&Y FDR less than 1e-10)

CategoryIDNameQ
CoexpressionM15664ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER6.19E-41
CoexpressionM41693TRAVAGLINI_LUNG_PROLIFERATING_MACROPHAGE_CELL2.92E-38
CoexpressionM3766SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP5.99E-38
CoexpressionM16010KOBAYASHI_EGFR_SIGNALING_24HR_DN2.32E-35
CoexpressionM18506CROONQUIST_IL6_DEPRIVATION_DN5.86E-34
DiseaseC2239176Liver carcinoma2.10E-45
DiseaseC4704874Mammary carcinoma, human1.27E-22
DiseaseC1458155Mammary neoplasms1.27E-22
DiseaseC1257931Mammary neoplasms, human1.27E-22
DiseaseC0678222Breast carcinoma2.38E-22
GO: Biological ProcessGO:0033993Response to lipid8.91E-16
GO: Biological ProcessGO:0014070Response to organic cyclic compound1.16E-13
GO: Biological ProcessGO:0043067Regulation of programmed cell death2.65E-13
GO: Biological ProcessGO:0009725Response to hormone2.65E-13
GO: Biological ProcessGO:1903047Mitotic cell cycle process4.21E-13
TFBSM30019HSD17B8_TARGET_GENES1.30E-15
CategoryIDNameQ
CoexpressionM15664ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER6.19E-41
CoexpressionM41693TRAVAGLINI_LUNG_PROLIFERATING_MACROPHAGE_CELL2.92E-38
CoexpressionM3766SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP5.99E-38
CoexpressionM16010KOBAYASHI_EGFR_SIGNALING_24HR_DN2.32E-35
CoexpressionM18506CROONQUIST_IL6_DEPRIVATION_DN5.86E-34
DiseaseC2239176Liver carcinoma2.10E-45
DiseaseC4704874Mammary carcinoma, human1.27E-22
DiseaseC1458155Mammary neoplasms1.27E-22
DiseaseC1257931Mammary neoplasms, human1.27E-22
DiseaseC0678222Breast carcinoma2.38E-22
GO: Biological ProcessGO:0033993Response to lipid8.91E-16
GO: Biological ProcessGO:0014070Response to organic cyclic compound1.16E-13
GO: Biological ProcessGO:0043067Regulation of programmed cell death2.65E-13
GO: Biological ProcessGO:0009725Response to hormone2.65E-13
GO: Biological ProcessGO:1903047Mitotic cell cycle process4.21E-13
TFBSM30019HSD17B8_TARGET_GENES1.30E-15
Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close